Acorda Announces Positive Vote by FDA Advisory Committee for Fampridine-SR

Wed, Oct 14, 2009 * Committee Views Fampridine-SR as Safe, Effective and Clinically Meaningful for Improving Walking in People with Multiple Sclerosis * Conference Call Scheduled for [...]

• Caroline says: Acorda had a special advisory board meeting requested by the FDA to discuss side effect issues in doses above 10mg. The outcome was positive for Acorda: in 10mg doses the drug appears safe and it helps people walk.